New incident report
Incident Report Number: 2017-4015
Registrant Reference Number: USA-BAYERBAH-2017-US0020504
Registrant Name (Full Legal Name no abbreviations): Bayer inc
Address: 2920 Matheson Blvd
City: Mississaugua
Prov / State: ON
Country: Canada
Postal Code: L4W 5R6
Domestic Animal
Country: UNITED STATES
Prov / State: CALIFORNIA
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. 11556-155
Product Name: Seresto Collar unknown
Other (specify)
collarYes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Dog / Chien
Afghan Hound
1
Unknown
Unknown
Unknown
Skin
Unknown / Inconnu
Unknown / Inconnu
System
Unknown / Inconnu
Unknown
Unknown
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On an unspecified date in 2016, a Afghan Hound canine of unknown signalment, in unknown condition, with no known concomitant medical conditions, had one Seresto (unspecified) (Flumethrin-Imidacloprid) collar placed around the neck by the owner. On an unspecified date post application in 2016, the dog died. No known necropsy was performed. Due to the sensitive nature of the communication, specific relevant event details were not obtained, nor will such be sought. The reason for the initial phone call was to discuss the use of the product and not to report the death of the patient. No further infomation is expected. Case is closed.
Death
N - Unlikely Death is not expected following appropriate topical product application as inconsistent with products pharmacological profile. Oral exposure to the collar is not expected to cause serious signs either. An overdose of 5 collars around the neck was investigated in adult cats and dogs for an 8 months period and in 10 week old kittens and 7 week old puppies for a 6 months period without causing serious signs. No signs of anaphylaxis reported which would have occurred in close proximity to the collar application. The information regarding the death of the dog was casually provided during an inquiry as the reporting party did not contact Bayer Animal Health to report the death of the animal but to inquire about additional product applications. Moreover in case of suspected product involvement, adverse event would have been reported in close proximity and not long time after. Considering these aspects, in spite of the limited information (animal details, time to onset, absence of necropsy results and medical history of the dog), considering known safety profile of the product, product relation is unlikely.